News | March 20, 2020
Pacific BioLabs would like to reassure its clients that we are continuing core operations at the moment and continue to support them in the development of their medical devices and […]
News | February 24, 2020
On 21 January 2020, Pacific BioLabs received unconditional approval for continuance of our ISO 17025:2017 accreditation, General Requirements for the Competence of Testing and Calibration Laboratories, as a result of […]
PBL clients are at the forefront of identifying new targets for drug discovery and development. Ophirex, a San Francisco Bay Area startup company founded by Matthew Lewin, M.D., Ph.D, is […]
News | September 30, 2019
Pacific BioLabs has purchased a new Sciex Triple Quad 6500+ LC-MS/MS. This instrument is a great addition to our existing AB Sciex API 4000 QTrap LC-MS/MS and Sciex 5600 Triple […]
The United States Pharmacopeia (USP) has published a new general chapter, the USP <60> which will become official on December 1, 2019. The chapter specifies tests to determine the presence […]
News | March 27, 2019
Pacific BioLabs is proud to announce successful accreditation for ISO 17025:2017, General Requirements for the Competence of Testing and Calibration Laboratories, through the ANSI-ASQ National Accreditation Board. PBL’s accreditation for […]
News | March 26, 2019
For their March issue, Medical Product Outsourcing Magazine interviewed Ryan Harper, PBL's Business Development Director, regarding recent medical device testing changes and developments. The article discusses current industry trends, additions […]